These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 33152323)
21. Catabolic pathways regulated by mTORC1 are pivotal for survival and growth of cancer cells expressing mutant Ras. Sung S; Choi J; Cheong H Oncotarget; 2015 Dec; 6(38):40405-17. PubMed ID: 26575954 [TBL] [Abstract][Full Text] [Related]
22. Promising Therapeutic Approach in Pancreatic Cancer: Metabolism-Related Genes. Choe S; Kwak W; Kim E; Shin S; Shin M; Koh HJ; Yoon H Front Biosci (Landmark Ed); 2024 Apr; 29(4):137. PubMed ID: 38682209 [TBL] [Abstract][Full Text] [Related]
23. MUC1 regulates PDGFA expression during pancreatic cancer progression. Sahraei M; Roy LD; Curry JM; Teresa TL; Nath S; Besmer D; Kidiyoor A; Dalia R; Gendler SJ; Mukherjee P Oncogene; 2012 Nov; 31(47):4935-45. PubMed ID: 22266848 [TBL] [Abstract][Full Text] [Related]
24. Targeting miR-21 for the therapy of pancreatic cancer. Sicard F; Gayral M; Lulka H; Buscail L; Cordelier P Mol Ther; 2013 May; 21(5):986-94. PubMed ID: 23481326 [TBL] [Abstract][Full Text] [Related]
25. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1. Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830 [TBL] [Abstract][Full Text] [Related]
26. Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression. Kemper M; Schiecke A; Maar H; Nikulin S; Poloznikov A; Galatenko V; Tachezy M; Gebauer F; Lange T; Riecken K; Tonevitsky A; Aigner A; Izbicki J; Schumacher U; Wicklein D J Exp Clin Cancer Res; 2021 Jun; 40(1):214. PubMed ID: 34174926 [TBL] [Abstract][Full Text] [Related]
28. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro. Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669 [TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer. Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915 [TBL] [Abstract][Full Text] [Related]
30. Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution. Hosein AN; Huang H; Wang Z; Parmar K; Du W; Huang J; Maitra A; Olson E; Verma U; Brekken RA JCI Insight; 2019 Jul; 5(16):. PubMed ID: 31335328 [TBL] [Abstract][Full Text] [Related]
31. Roles of autophagy and metabolism in pancreatic cancer cell adaptation to environmental challenges. Maertin S; Elperin JM; Lotshaw E; Sendler M; Speakman SD; Takakura K; Reicher BM; Mareninova OA; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G524-G536. PubMed ID: 28705806 [TBL] [Abstract][Full Text] [Related]
32. Translational therapeutic opportunities in ductal adenocarcinoma of the pancreas. Hidalgo M; Von Hoff DD Clin Cancer Res; 2012 Aug; 18(16):4249-56. PubMed ID: 22896691 [TBL] [Abstract][Full Text] [Related]
33. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma. Fu Y; Liu S; Zeng S; Shen H Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370 [TBL] [Abstract][Full Text] [Related]
34. TIMP1 Triggers Neutrophil Extracellular Trap Formation in Pancreatic Cancer. Schoeps B; Eckfeld C; Prokopchuk O; Böttcher J; Häußler D; Steiger K; Demir IE; Knolle P; Soehnlein O; Jenne DE; Hermann CD; Krüger A Cancer Res; 2021 Jul; 81(13):3568-3579. PubMed ID: 33941611 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3. Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446 [TBL] [Abstract][Full Text] [Related]
36. Metabolism addiction in pancreatic cancer. Blum R; Kloog Y Cell Death Dis; 2014 Feb; 5(2):e1065. PubMed ID: 24556680 [TBL] [Abstract][Full Text] [Related]